PRESCRIBING FOR THE PSA AND FINALS DR FRANCESCA BONORA
|
|
- Daisy Norman
- 5 years ago
- Views:
Transcription
1 PRESCRIBING FOR THE PSA AND FINALS DR FRANCESCA BONORA
2 WHAT WE WILL COVER HOW TO PREPARE FOR THE PSA EXAM HOW SCENARIOS APPLY TO PRESCRIBING FOR FINALS
3 THE PSA EXAM
4 For full details of what could be asked: prescribingsafetyassessment.ac.uk/aboutpsa Click on PSA blueprint for November 2017 PDF
5 EXAMPLES OF ITEM STYLES
6 SECTION 1 PRESCRIBING Decide on the most appropriate prescription (drug, dose, route and frequency), based on the clinical circumstances Write a safe, effective and legal prescription 8 questions worth 10 marks each
7 Make sure you sign the prescriptions with your full surname (not initials) don t lose the easy marks
8 HOW TO PREPARE Exam is time pressured, so LEARN TREATMENT ALGORITHMS: Acute conditions eg acute asthma attack, acute heart failure Chronic conditions e.g. depression, reflux oesophagitis Presenting symptoms e.g. pain Find these in the back of the Oxford handbook
9 OXFORD HANDBOOK ALGORITHMS
10 THIS BOOK IS GREAT PASS THE PSA, 1E, FEB 2014, BY WILL BROWN BSC MBBS MRCP(UK) FHEA AND KEVIN W LOUDON
11 ANAPHYLAXIS TREATMENT ALGORTIHMS ACUTE ASTHMA MAKE THESE FOR YOURSELF FOR ALL COMMONEST ACUTE AND CHRONIC MEDICAL CONDITIONS PASS THE PSA, 1E, FEB 2014, BY WILL BROWN BSC MBBS MRCP(UK) FHEA AND KEVIN W LOUDON
12 HOW TO PREPARE If you can t remember use treatment summaries in the online BNF during the exam CTRL + F is your best friend!
13 BNF TREATMENT SUMMARIES CTRL + F
14 PRESCRIBING CONTROLLED DRUGS WHICH IS CORRECT? 29 Andrew Smith 01/10/87 Perrin Lecture Theatre 29 Andrew Smith 01/10/87 Perrin Lecture Theatre MORPHINE SULPHATE 10mg oral tablets Take one tablet, three times daily Please supply 28 (TWENTY-EIGHT) tablets. MORPHINE SULPHATE 10mg oral tablets Take one tablet, three times daily. Please supply 28 10mg (TEN MILLIGRAM) tablets.
15 PRESCRIBING CONTROLLED DRUGS WHICH IS CORRECT? 29 Andrew Smith 01/10/87 Perrin Lecture Theatre 29 Andrew Smith 01/10/87 Perrin Lecture Theatre MORPHINE SULPHATE 10mg oral tablets Take one tablet, three times daily Please supply 28 (TWENTY-EIGHT) tablets. MORPHINE SULPHATE 10mg oral tablets Take one tablet, three times daily. Please supply 28 10mg (TEN MILLIGRAM) tablets. It s the total amount that you need to specify
16 PRESCRIBING CONTROLLED DRUGS Include the name and address of the patient. State the name and strength of the drug State the dose and frequency TOTAL AMOUNT must be written in WORDS AND FIGURES
17 WHAT DOSE SHOULD YOU PRESCRIBE?
18 WHAT DOSE SHOULD YOU PRESCRIBE?
19 SECTION 2 PRESCRIPTION REVIEW Identify prescriptions (drugs, doses or routes) that are inappropriate, unsafe or ineffective from amongst the current list of prescribed medicines 8 items worth 4 marks each
20 PRESCRIPTION REVIEW 11/1/17 PO FUROSEMIDE 40mg 11/1/17 PO PREDNISOLONE 40mg
21 PRESCRIPTION REVIEW 11/1/17 PO FUROSEMIDE 40mg 11/1/17 PO SHOULD BE GIVEN IN MORNING WILL KEEP PATIENT AWAKE! PREDNISOLONE 40mg SHOULD BE GIVEN IN MORNING WILL KEEP PATIENT AWAKE!
22 SPOT THE MISTAKES
23 SPOT THE MISTAKES INCORRECT DOSE SHOULD BE 62.5 MICROGRAMS WHAT TYPE? WRITE UNITS (NOT JUST U ) TECHNICALLY SHOULD BE PRESCRIBED ON THE INSULIN AREA OF THE CHART! WRITE MICROGRAMS IN FULL
24 FLUID CHART ERRORS 11/1/17 0.9% Saline 1 litre KCl 40mmol STAT A.L.S 11/1/17 Red Blood Cells 2 units hours A.L.S 11/1/17 50% Dextrose 1 litre 12 hours A.L.S
25 FLUID CHART ERRORS 11/1/17 0.9% Saline 1 litre KCl 40mmol STAT A.L.S This amount of potassium must be given over at least 4 hours due to risk of arrhythmias 11/1/17 Red Blood Cells 2 units hours A.L.S Each unit needs to be prescribed separately Has to be discarded 4 hours (from leaving the lab) 11/1/17 50% Dextrose 1 litre 12 hours A.L.S 50% Dextrose is irritant to veins. It should only be given in small volumes (20% should preferably be used if trying to reverse hypoglycaemia)
26 SECTION 3 PLANNING MANAGEMENT Deciding which treatment would be most appropriate to manage a particular clinical situation 8 items worth 2 marks each Choose most appropriate treatment from list of 5
27 COMMON ACUTE CONDITIONS KNOW THE TREATMENT ALGORITHMS FOR: STEMI NSTEMI ACUTE LEFT VENTRICULAR FAILURE TACHYCARDIA WITH PULSE ANAPHYLAXIS ACUTE ASTHMA EXACERBATION PNEUMONIA PE GI BLEED BACTERIAL MENINGITIS SEIZURE STATUS EPILEPTICUS STROKE HYPERGLYCEMIA DKA AND HHS AKI POISONING
28 COMMON CHRONIC CONDITIONS KNOW THE TREATMENT ALGORITHMS FOR: HYPERTENSION CHRONIC HEART FAILURE STROKE PREVENTION STABLE ANGINA CHRONIC ASTHMA COPD DIABETES INSOMNIA CONSTIPATION DIARRHOEA PAIN
29 SECTION 4 PROVIDING INFORMATION Decide the most important piece of information that should be provided to patients to allow them to choose whether to take the medicine and to enhance its safety and effectiveness Six items worth 2 marks
30 PROVIDING INFORMATION DRUG RAMIPRIL GLICLAZIDE METHOTREXATE WARFARIN LONG TERM STEROIDS SSRI INSULIN BISPHOSPHONATE INFORMATION STOP IN PREGNANCY TERATOGENIC EAT REGULARLY, DON T SKIP MEALS HYPO RISK REGULAR FBC NEUTROPENIA RISK MONITOR INR - BLEEDING TAKE BISPHOSPHONATE OSTEOPEROSIS RISK DON T STOP SUDDENLY CONTACT DOCTOR IF THOUGHT OF SELF HARM DOSE MAY NEED TO BE INCREASED IF UNWELL TAKE WITH FULL GLASS OF WATER AND REMAIN UPRIGHT FOR 1 HOUR
31 SECTION 5 CALCULATION SKILLS Making an accurate drug dosage calculation based on numerical information Recording answer accurately with appropriate units of measurement 8 items worth 2 marks
32 MAKE SURE YOU PRACTICE Correct number of tablets to achieve a required dose Making necessary dose adjustments based on weight or body surface area Diluting a drug for administration in an infusion pump
33 DRUG RATIOS 1% means 1g in 100ml or 10mg in 1ml for weight/volume (w/v) calculations 1g in 100g for weight/weight calculations
34 ADRENALINE RATIOS ANAPHYLAXIS 0.5mg = 0.5ml of 1 in 1,000 IM Remember 1 in 1,000 means: 1g in 1000 ml or 1000mg in 1000ml or 1ml in 1mg Therefore 0.5ml = 0.5mg CARDIAC ARREST 1mg = 10ml of 1 in 10,000 IV Remember 1 in 10,000 means: 1g in 10,000 ml or 1,000mg in 10,000ml or 1mg in 10ml
35 Dosage Calculations Always convert to the same units and then: D (What you want) H (What you ve got) x V (volume it is in) = Dose Try some practice questions:
36 SECTION 6 ADVERSE DRUG REACTIONS Likely adverse reactions to specific drugs, potentially dangerous interactions, managing adverse effects of a drug 8 items worth 2 marks each
37 ADVERSE DRUG REACTIONS THE CTRL + F SECTION Adverse effects caused by commonly prescribed drugs such as calcium channel blockers, beta2-agonists, non-steroidal anti-inflammatory drugs, aminoglycoside antibiotics, etc. Most likely drug to have caused adverse effect e.g. renal impairment, hepatic dysfunction, hypokalaemia, urinary retention, etc. Potential interactions between medicines e.g. warfarin-statins, inhibitors NSAIDs-ACE How to treat an adverse drug reaction e.g. acute anaphylaxis, excessive anticoagulation, drug-induced hypoglycaemia, diuretic-induced dehydration etc.
38 SPOT THE POTENTIAL ADVERSE EFFECT
39 SPOT THE POTENTIAL ADVERSE EFFECT POTASSIUM BOTH DRUGS CAN CAUSE HYPERKALAEMIA
40 SPOT THE POTENTIAL ADVERSE EFFECT Some drugs causing HYPERKALAEMIA ACE Inhibitors Angiotensin Receptor Blockers (ARB) Beta Blockers Digoxin Heparin NSAIDs Spironolactone Transfusions of RBC Trimethoprim POTASSIUM BOTH DRUGS CAN CAUSE HYPERKALAEMIA
41 WHAT IS THIS PATIENT AT RISK OF?
42 WHAT IS THIS PATIENT AT RISK OF? PHENYTOIN TOXICITY Enzyme inhibitor Enzyme inducer (but relatively less so)
43 ENZYME INHIBITORS AND INDUCERS INDUCERS Increase enzyme activity Reduce drug concentration PC BRAS Phenytoin Carbamazepine Barbituates Rifampicin Alcohol (chronic excess) Sulphonylureas INHIBITORS Reduce enzyme activity Increase drug concentration AODEVICES Allopurinol Omeprazole Disulfiram Erythromycin Valproate Isoniazid Ciprofloxacin Ethanol (acute itntoxication) Sulphonamides
44 WHAT IS THIS PATIENT AT RISK OF? 11/1/17 PO OMEPRAZOLE 40mg 11/1/17 PO PAROXETINE 20mg
45 WHAT IS THIS PATIENT AT RISK OF? 11/1/17 PO 40mg 11/1/17 PO OMEPRAZOLE PAROXETINE Drugs commonly causing HYPONATRAEMIA Thiazide diuretics Amiloride Carbamazepine Sulphonylureas (but not Gliclazide) Proton pump inhibitors Antidepressants, particularly SSRIs ACE inhibitors and ARBs Opiates 20mg
46 NEPHROTOXIC & HEPATOTOXIC DRUGS NEPHROTOXIC ACE Inhibitors Aminoglycosides NSAIDs Methotrexate HEPATOTOXIC Amiodarone Isoniazid Co-amoxiclav NSAIDs Statins Anti-fungals Anti-retrovirals
47 PENICILLIN ALLERGY FLUCLOXACILLIN ERYTHROMYCIN AMIKACIN MEROPENEM CO-AMOXICLAV TAZOCIN METRONIDAZOLE RIFAMPACIN CEFTRIAXONE AVOID CAUTION SAFE
48 PENICILLIN ALLERGY
49 ALLERGIC REACTION MANAGEMENT A patient recently given Tazocin despite a Type 1 Penicillin allergy develops shortness of breath, stridor and a widespread urticarial rash. Choose 3 appropriate treatments: A) Chlorphenamine 4mg, PO B) Adrenaline 10ml of 1:10000, IV C) Adrenaline 10ml of 1:10000, IM D) Adrenaline 0.5ml of 1:1000, IV E) Adrenaline 0.5ml of 1:1000, IM F) Hydrocortisone 200mg, IV G) Chlorphenamine 10mg, IV
50 ALLERGIC REACTION MANAGEMENT A patient recently given Tazocin despite a Type 1 Penicillin allergy develops shortness of breath, stridor and a widespread urticarial rash. Choose 3 appropriate treatments: A) Chlorphenamine 4mg, PO only after resuscitation B) Adrenaline 10ml of 1:10000, IV cardiac arrest, 1mg C) Adrenaline 10ml of 1:10000, IM never used D) Adrenaline 0.5ml of 1:1000, IV never used E) Adrenaline 0.5ml of 1:1000, IM e.g. 0.5mg F) Hydrocortisone 200mg, IV G) Chlorphenamine 10mg, IV
51 SECTION 7 - DRUG MONITORING How to monitor the beneficial and harmful effects of medicines. 8 items worth 2 marks
52 DRUG LEVEL MONITORING - EXAMPLES Some detail on specific drugs: Drug Half-life Timing Toxic Level* Major Toxic Effects Gentamicin 2h Trough After 2-3 doses >2mcg/ml Nephrotoxity, irreversible ototoxicity Phenytoin 20-40h Trough After 2-3 days Total >20mcg/ml Free >2mcg/ml Nystagmus, diplopia, ataxia, confusion, hyperglycaemia Aminophylline 4-16hr N/A 4-6hrs after starting IV infusion Theophylline Trough 5 days >20mcg/ml Arrhythmias, convulsions, hypotension Digoxin 24-36h Trough 1 week >2ng/ml Arrhythmias, visual disturbance, anorexia
53 OTHER DRUG MONITORING DRUG WARFARIN LEVOTHYROXINE ACE INHIBITORS / DIURETICS CLOZAPINE ORAL CONTRACEPTION MONITOR INR TFT (CHANGE DOSE EVERY 4 WEEKS) U&Es FBC BLOOD PRESSURE
54 GENTAMICIN DOSING Hartford nomogram: guides when to give patient next dose, based on blood concentration and the time the measurement was taken E.g. if concentration is 8mg/ml, 8h after start of infusion what is correct dosing interval?
55 GENTAMICIN DOSING Hartford nomogram: guides when to give patient next dose, based on blood concentration and the time the measurement was taken Answer: 36h
56 SECTION 8 DATA INTERPRETATION Make an appropriate change to a prescription based on results of investigations 6 items worth 2 marks
57 PARACETAMOL OVERDOSE Activated charcoal: consider if >150mg/kg has been taken within a 1 hour period. N-acetylcysteine (NAC): Single overdose check level at 4h and use the nomogram (use nomogram when OD has been taken between 4-8h ago) If plasma concentration levels are above the treatment line then you need to treat Staggered overdose (>1h) cannot accurately calculate levels so treat
58 PARACETAMOL OVERDOSE E.g. Patient takes 10 paracetamol tablets at Blood test taken at Paracetamol concentration 0.4mmol/litre
59 PARACETAMOL OVERDOSE DON T TREAT
60 PRESCRIBING SCENARIOS FINALS All the same scenarios in different formats OSCES Prescribe warfarin Prescribe an IM injection eg vitamin B12 Spot the prescription errors Write fluid prescription and calculate drip rates Presenting a history and giving treatment recommendations eg hypertension WRITTEN PAPER Know your treatment algorithms for acute and chronic conditions Data interpretation questions remember side effects of drugs and how they can affect blood results
61 GOOD LUCK!!
Prescribing. Dr Andrew Smith
Prescribing Dr Andrew Smith Outline from 2014 Rules of Prescribing Prescribing Controlled Drugs Liver/Renal Disease Pregnancy/Breastfeeding Prescribing in the Elderly Allergies Adverse Drug Reactions Drug
More informationPrescribing The PSA, Finals and Beyond. Dr Andrew Smith
Prescribing The PSA, Finals and Beyond Dr Andrew Smith Outline Plus: Some practical tips for the PSA Slides on Prescribing Theory There is a lot of overlap of knowledge which may be tested in various way
More informationPrescribing. Dr Andrew Smith
Prescribing Dr Andrew Smith Outline Rules of Prescribing Prescribing Controlled Drugs Liver/Renal Disease Pregnancy/Breastfeeding Prescribing in the Elderly Allergies Adverse Drug Reactions Drug Level
More informationPSA Tutorial. Dr Jonny Whitfield Honorary Clinical Senior Lecturer Aberdeen University Lead for PSA
PSA Tutorial Dr Jonny Whitfield Honorary Clinical Senior Lecturer Aberdeen University Lead for PSA PSA Basic facts about PSA and timings Overview of each section from the PSA Blueprint with worked examples
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationLung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC) Indication: First line in radical/induction treatment in locally advanced NSCLC First line palliative treatment in advanced/metastatic
More informationLung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC) Indication: First line in radical/induction treatment in locally advanced NSCLC First line palliative treatment in advanced/metastatic
More information2015 Edition. Trust Medicines Formulary
2015 Edition Trust Medicines Formulary Introduction Trust Medicines Formulary This formulary summarises all medicines used within the Trust, the Trust defines medicines as any substance, controlled or
More informationECX. Anti-emetics: Day 1: highly emetogenic Days 2 21: mildly emetogenic
Page 1 of 5 As an alternative to ECF: For locally advanced (inoperable) or metastatic oesophageal or gastric cancer; peri-operative use in oesophageal or gastric cancer; adenocarcinoma of unknown primary
More informationDrug Prescribing. Ravi Menon
Drug Prescribing Ravi Menon Introduction Approximately 7,000 individual drug doses are administered each day in a 'typical' NHS hospital, 70% of which are prescribed by first year graduates and senior
More informationMATRIX (Methotrexate, Cytarabine, Thiotepa and Rituximab)
MATRIX (Methotrexate, Cytarabine, Thiotepa and Rituximab) Indication First line treatment of primary CNS lymphoma. ICD-10 codes Codes with a prefix C85 Regimen details Day Drug Dose Route 1 and 6 Rituximab
More informationSalicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre.
Aspirin poisoning CLINICAL FEATURES Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre. Severe poisoning causes
More informationAntibiotic Class Interacting Drug Comment Penicillins e.g. Amoxicillin Co amoxiclav Flucloxacillin Phenoxymethylpenicillin
Antibiotic Class Interacting Drug Comment Penicillins Methotrexate Amoxicillin Co amoxiclav Flucloxacillin Phenoxymethylpenicillin Cephalosporins Cefaclor Cefixime Cefuroxime Cephalexin Cefazolin* Ceftriaxone*
More informationCarboplatin + Paclitaxel Cancer of the Cervix
Carboplatin + Paclitaxel Cancer of the Cervix Background: Topotecan in combination with cisplatin is recommended as a treatment option for women with recurrent or stage IVB cervical cancer only if they
More informationCisplatin / Paclitaxel Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol Cisplatin / Paclitaxel Gynaecological Cancer PROCTOCOL REF: MPHAGYNCIP (Version No: 1.0) Approved for use in: First line treatment for stage Ib-IV with minimal residual
More informationCisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer
Cisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer Page 1 of 5 Indication: Confirmed HER2-positive (3+ or FISH+) metastatic adenocarcinoma of the stomach or gastrooesophageal junction. Patient
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Dr Susannah O Sullivan Department of Pharmacology University of Auckland 2 Objectives Explain the potential for interacting drugs to cause beneficial and
More informationWhat is Hypertension?
What is Hypertension? What is hypertension? Hypertension is also known as high blood pressure. Our blood needs to be under pressure to make it move around the body, but when it is too high this causes
More informationCarboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol Carboplatin / CARBO/CAELYX Gynaecological Cancer PROCTOCOL REF: MPHAGYNCCX (Version No: 1.0) Approved for use in: Advanced ovarian cancer in women who have progressed
More informationTHE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane
Systemic Anti Cancer Treatment Protocol EDP + mitotane PROCEDURE REF: MPHAHANEDP (Version No: 1.0) Approved for use in: Symptomatic treatment for advanced (unresectable, metastatic or relapsed) adrenocortical
More informationBack to Basics: The Basics of Medication Monitoring
DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational
More informationAppendix 5: Hepatic impairment
Appendix 5: Hepatic impairment Liver disease may alter the response to drugs. However, the hepatic reserve appears to be large and liver disease has to be severe before important changes in drug metabolism
More informationDR J HARTY / DR CM RITCHIE / DR M GIBBONS
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date
More informationPATIENT INFORMATION LEAFLET PEARINDA PLUS
SCHEDULING STATUS OF THE MEDICINAL PRODUCT S3 NAME OF MEDICINAL PRODUCT 2 (Tablet) 4 (Tablet) Read this leaflet carefully before you start taking. Keep this leaflet. You may need to read it again. If you
More informationCisplatin Vinorelbine (Oral) therapy +/- radiotherapy
1 REGIMEN TITLE: Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy Page 1 of 5 Indication: First line in Radical/ Induction, Adjuvant and Advanced & Palliative treatment of Non-small cell lung cancer
More informationUnderstanding your take home medications from the surgical ward. Information for Patients
Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for
More informationCisplatin and Pemetrexed (NSCLC, mesothelioma)
Cisplatin and Pemetrexed (NSCLC, mesothelioma) Indication First-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) if the histology of the tumour has been confirmed as
More informationDose. Route. Units. Given. Special situations. Dose. Route. Units. Given. Special situations
Chapter 3 Cardiology Georgia Woodfield ASPIRIN FONDAPARINUX 300 once only in acute MI 75 in primary/ secondary prevention of thrombus formation and thromboembolic disease or PR; can also be given via nasogastric
More informationAppendix 1: Interactions
Appendix 1: Interactions Two or more drugs given at the same time may interact with each other. The interaction may be potentiation or antagonism of one drug by another, or occasionally some other. Drug
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationR-IDARAM. Dexamethasone is administered as an IV infusion in 100mL sodium chloride 0.9% over 30 minutes.
R-IDARAM Indication Secondary CNS lymphoma ICD-10 codes Codes with a prefix C85 Regimen details Day Drug Dose Route 1 Rituximab 375mg/m 2 IV infusion 1 Methotrexate 12.5mg Intrathecal 1 Cytarabine 70mg
More informationDRUGS FOR VIVA. IAP UG Teaching slides
DRUGS FOR VIVA 1 Q:1 INJ SODIUM BICARBONATE 1. What all strengths are available? 2. What are the clinical indications for IV sodium bicarbonate? 3. How do you administer this drug? 2 ANS: 1. Available
More informationLET - Maths, Stats & Numeracy
Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than
More information(R) CODOX M / (R) IVAC
(R) CODOX M / (R) IVAC Indication Burkitt's or Burkitt's-like lymphoma, especially those with 1 or more of the following poor risk criteria: - Raised LDH level - WHO performance status 2-4 - Ann Arbor
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationTHE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti-Cancer Treatment Protocol. Abiraterone. PROCTOCOL REF: MPHAABIRA (Version No: 1.
Systemic Anti-Cancer Treatment Protocol Abiraterone PROCTOCOL REF: MPHAABIRA (Version No: 1.0) Approved for use in: The treatment of metastatic castration resistant prostate cancer in adult men who are
More informationCisplatin / 5-Fluorouracil for Vulval Cancer
Cisplatin / 5-Fluorouracil for Vulval Cancer Indication: Palliative therapy in patients with Vulval Cancer Regimen details: Cisplatin 75mg/m 2 (*) IV 5-Fluorouracil (5-FU) 1000mg/m 2 /24 hours IV D4 (*)Consider
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationsulfonamide antibiotics
Appropriate use of sulfonamide antibiotics What are sulfonamides and how do they work? Sulfonamides are a group of synthetic medicines that contain the sulfonamide chemical group. As well as antibiotics,
More informationAntiallergics and drugs used in anaphylaxis
Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing
More informationCisplatin100 plus Radiotherapy for locally Advanced Squamous Cell Carcinoma Head and Neck
Cisplatin100 plus Radiotherapy for locally Advanced Squamous Cell Carcinoma Head and Neck Indication: 1) Concomitant chemo-radiotherapy for locally advanced squamous cell carcinoma head and neck 2) Post-operative
More informationDERBY-BURTON LOCAL CANCER NETWORK FILENAME SMILE.DOC CONTROLLED DOC NO: HCCPG B57 CSIS Regimen Name: SMILE. SMILE chemotherapy
SMILE chemotherapy Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Indication Extranodal
More informationCisplatin and Gemcitabine (bladder)
Cisplatin and Gemcitabine (bladder) Indication Palliative therapy for locally advanced or metastatic bladder cancer in patients with good renal function. Palliative therapy for urothelial transitional
More informationGet Healthy Stay Healthy
Hypertension Management WHAT IS HYPERTENSION (HIGH BLOOD PRESSURE)? Blood pressure is a measure of how hard the blood pushes against the walls of your arteries as it moves through your body. It is normal
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you
More informationCardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention
Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,
More informationInterface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE
Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable
More informationTop tips for surviving your first on call Dr Maleeha Rizvi
Top tips for surviving your first on call Dr Maleeha Rizvi Specialist Registrar in Cardiology University Hospital Lewisham Overview Practical points The Bleep and prioritising on call Cardiac arrests Prescribing
More informationCisplatin / 5-Fluorouracil (+ Trastuzumab) in Gastric Cancer
Cisplatin / 5-Fluorouracil (+ Trastuzumab) in Gastric Cancer Indication: Confirmed HER2-positive (3+ or FISH+) metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. For Trastuzumab doses
More informationCLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES
National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) CP11 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION The
More informationUsing the BNF. CWFS F1 Programme Safe Prescribing Module
Using the BNF CWFS F1 Programme Safe Prescribing Module Know Your BNF Guidance on prescribing - Controlled drugs and dependence - Prescribing in palliative care/elderly/children Emergency treatment of
More informationUNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17
LJW3 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful
More informationModule. Module. Managing Other Chronic Conditions. Managing Other Chronic Conditions
Managing Other Chronic Conditions 8 Managing Other Chronic Conditions Taking Control of Heart Failure Important Information Please write down important contact information in the space below. You may also
More informationFlecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.
1 Consumer Medicine Information Flecainide acetate Tablets 50 mg & 100 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions
More informationCisplatin + Etoposide IV / Oral therapy followed by Chemo-radiotherapy in Small Cell Carcinoma of the Cervix
Cisplatin + Etoposide IV / Oral therapy followed by Chemo-radiotherapy in Small Cell Carcinoma of the Cervix Indication: Neoadjuvant chemotherapy followed by Chemo-radiotherapy in Small Cell Carcinoma
More information2. Adverse Drug Reactions
2. Adverse Drug Reactions Background Medicines Information Centres receive many enquiries specifically about adverse drug reactions (ADRs), as well as a large number featuring related patient safety issues
More informationNEXIUM INTRAVENOUS esomeprazole sodium
NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain
More informationName Date Period. West Nomogram
West Nomogram A West Nomogram is used to help adjust medication calculations for children. Because children are smaller than adults, they are usually given smaller amounts of medication. The adjustment
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments
ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest
More informationTIP: Paclitaxel / Ifosfamide / Cisplatin in Relapsed Germ Cell Tumour
TIP: Paclitaxel / Ifosfamide / Cisplatin in Relapsed Germ Cell Tumour Indication: Second line therapy in Relapsed Germ Cell Tumours Regimen details: Paclitaxel 175mg/m 2 IV Cisplatin 20mg/m 2 IV - D5 Ifosfamide
More informationACETYLCYSTEINE INJECTION
ACETYLCYSTEINE INJECTION 1. Name of the medicinal product Acetylcysteine 200 mg/ml Injection 2. Qualitative and quantitative composition Acetylcysteine 200mg per ml (as N-acetylcysteine) Each 10ml ampoule
More information(R) CHOEP. May be used for stage IA - IV Diffuse Large B Cell non-hodgkin lymphoma in combination with rituximab.
(R) CHOEP Indication Treatment of stage IA - IV T cell non-hodgkin lymphoma as an alternative to CHOP in younger, fitter patients with normal LDH level. May be used for stage IA - IV Diffuse Large B Cell
More informationDrug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
More informationPrescribing and Administration of Analgesia within Maternity
Prescribing and Administration of Analgesia within Maternity CONTENTS Introduction and Who The Guideline Applies To... 2 UHL Paracetamol Prescribing Guideline... 2 Oral dosing... 2 Intravenous dosing...
More informationBACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER BACTRIM tablets CO-TRIMOXAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationAppendix 4: Renal impairment
Appendix 4: Renal impairment Reduced renal function may cause problems with drug therapy for the following reasons: 1. The failure to excrete a drug or its metabolites may produce toxicity. 2. The to some
More informationCLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES
National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) MMCP05 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION
More informationPatient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG Lancashire North CCG Fylde & Wyre CCG East Lancashire CCG Change history Version
More informationTIP Paclitaxel, Ifosfamide and Cisplatin
Systemic Anti Cancer Treatment Protocol TIP Paclitaxel, Ifosfamide and Cisplatin PROTOCOL REF: MPHATIPGC (Version No: 1.0) Approved for use in: Second line treatment of germ cell tumours Dosage: Drug Dosage
More informationGuidelines for Medicines Optimisation in Patients with Acute Kidney Injury
Guidelines for Medicines Optimisation in Patients with Acute Kidney Injury Publication July 2016 Guidelines for Medicines Optimisation in Patients with Acute Kidney Injury Review date February 2018 Table
More informationPATIENT MEDICATION INFORMATION
- 1 - READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION TENORMIN atenolol tablets Read this carefully before you start taking TENORMIN and each time you get a refill.
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Hyponatraemia in Adults
Southern Derbyshire Shared Care Pathology Guidelines Hyponatraemia in Adults Purpose of Guideline The investigation and management of adult patients with newly diagnosed hyponatraemia. Hyponatraemia can
More informationClinical Pharmacology and Prescribing
1 Clinical Pharmacology and Prescribing Dr Susannah O Sullivan Department of Pharmacology 2 Objectives Recognise the importance of clinical pharmacology as the scientific discipline that underpins a rational
More informationFEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel)
FEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel) Indication Adjuvant or neo-adjuvant treatment for high risk early and locally advanced breast cancer. (NICE CG80) ICD-10 codes Codes
More informationMedication Calculations - part 1
Medication Calculations - part 1 Learning Skills Introduction: Common calculations required in nursing include finding volumes needed for oral or injected doses and working out IV infusion flow and drip
More informationPrescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry
Prescribing in the Elderly Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry 24 th September 2014 Objectives Understand the significance of polypharmacy in the elderly Become familiar with the
More informationPHARMACOLOGY AND PHARMACOKINETICS
DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician
More informationCABAZITAXEL Prostate Cancer
Systemic Anti-Cancer Treatment Protocol CABAZITAXEL Prostate Cancer PROCTOCOL REF: MPHACABAZ (Version No: 1.0) Approved for use in: Cabazitaxel in combination with prednisolone is a treatment option for
More informationChapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given
Chapter 5 Gastroenterology Georgia Woodfield TERLIPRESSIN CIPROFLOXACIN 2 initial dose 500 Every 4 hours until bleeding controlled can be reduced to 1 after initial dose if side effects develop or if patient
More informationPACKAGE LEAFLET: Information for the patient FUROSEMID Tablets - 40 mg Solution for injection - 20 mg / 2 ml (Furosemide)
PACKAGE LEAFLET: Information for the patient FUROSEMID Tablets - 40 mg Solution for injection - 20 mg / 2 ml (Furosemide) Read this leaflet carefully before you start taking this medicine. - Keep this
More informationAdrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5
Quick Reference Guide for: Cardiac Arrest Medicines Box (BLUE) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999 must
More informationElements for a Public Summary Overview of disease epidemiology
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Acute pain usually responds to medication and should settle in less than three months. Inadequate pain relief may lead to other
More informationRefer to the manufacturers prescribing information or instructions for use before taking any medications.
Medicines Medicines play an important role in treatment for patients who have had a heart attack or who have heart failure. In most cases, people who have had a heart attack or who have heart failure require
More informationEDEMID FORTE 500mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER EDEMID FORTE 500mg tablets FUROSEMIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationOur Commitment to Quality and Patient Safety Core Measures
Calvert Memorial Hospital is committed to our community, with a focus on patient-centered care. High quality and safe patient care is not our goal, it is our priority. That means delivering the best possible
More informationPanobinostat, Bortezomib and Dexamethasone
Panobinostat, Bortezomib and Dexamethasone Indication Treatment of relapsed/refractory multiple myeloma in patients who have received at least 2 prior regimens, including bortezomib and an immunomodulatory
More informationCisplatin and Fluorouracil
Cisplatin and Fluorouracil Indication Neo-adjuvant treatment of nasopharyngeal head and neck cancer (stage II-IV) or bulky disease at other head and neck sites. Performance Status 0-1 ICD-10 codes Codes
More informationGemcitabine, Carboplatin and Bevacizumab (gynae)
Gemcitabine, Carboplatin and Bevacizumab (gynae) Indication Second line advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. WHO performance status 0 or 1. (Funding via the CDF) ICD-10
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationIt does not contain all the available information. It does not take the place of talking to your doctor or nurse.
DYNASTAT (die-na-stat) parecoxib Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Dynastat powder for injection. It does not contain all the available
More informationELECTROLYTES RENAL SHO TEACHING
ELECTROLYTES RENAL SHO TEACHING Metabolic Alkalosis 2 factors are responsible for generation and maintenance of metabolic alkalosis this includes a process that raises serum bicarbonate and a process that
More informationDialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride
PACKAGE LEAFLET: INFORMATION FOR THE USER Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationGLUCOPHAGE 500 mg mg mg
GLUCOPHAGE 500 mg - 750 mg - 1000 mg Prolonged release tablets metformin hydrochloride This medicine is intended for adult patients only Read all of this leaflet carefully before you start taking this
More information5 MUSCULOSKELETAL SYSTEM
5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationBEVACIZUMAB (AVASTIN ) & Paclitaxel PROTOCOL
Bevacizumab (Avastin ) & Paclitaxel The treatment of Advanced Breast Cancer DRUG ADMINISTRATION Da Drug Daily Dose Route Diluent & Rate y 250mls Sodium Day 1,15 Bevacizumab 10 mg/kg Infusion Chloride 0.9%*
More informationCarboplatin, Paclitaxel and Bevacizumab (gynae)
Carboplatin, Paclitaxel and Bevacizumab (gynae) Indication First line treatment of recurrent or metastatic cervical cancer. WHO performance status 0 or 1. First line treatment of advanced epithelial ovarian,
More informationCHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX
CHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX Therapeutic Indications: Venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion
More information